Assessment of Macrophage Activation syndromE in STill's Disease in Italy
NCT06992505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2025-12-02
Summary
Assessment of macrophage activation syndrome in Still's disease:
retrospective chart analysis of patient history, symptom resolution and treatment characteristics in Italy
Conditions
- Macrophage Activation Syndrome (MAS)
- Still Disease, Juvenile Onset
- Still's Disease, Adult-Onset
Sponsors & Collaborators
-
Swedish Orphan Biovitrum
lead INDUSTRY
Principal Investigators
-
Study Physician · Swedish Orphan Biovitrum
Eligibility
- Min Age
- 6 Months
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-06
- Primary Completion
- 2025-11-27
- Completion
- 2025-11-27
Countries
- Italy
Study Locations
More Related Trials
-
The Natural History of Alpha-Mannosidosis
NCT00498420 ·Status: COMPLETED
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
New Candidate Criteria for Diagnosis of Macrophage Activation Syndrome
NCT01095146 ·Status: UNKNOWN
-
International Registry for Patients With Castleman Disease
NCT02817997 ·Status: RECRUITING
-
Mastocytosis Registry (of Zurich)
NCT06466889 ·Status: RECRUITING
-
Characteristics of Mast Cells in Mastocytosis
NCT00001356 ·Status: COMPLETED
-
Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission
NCT01265082 ·Status: UNKNOWN
-
(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation
NCT04811365 ·Status: COMPLETED
-
Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis
NCT04314193 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease
NCT01400503 ·Status: COMPLETED ·Phase: PHASE2
-
Mast Cell Connect: A Registry for Patients With Mastocytosis
NCT02620254 ·Status: COMPLETED
-
Natural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA)
NCT02998710 ·Status: RECRUITING
-
Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.
NCT02993133 ·Status: COMPLETED ·Phase: PHASE3
-
CHronic Nonbacterial Osteomyelitis International Registry
NCT04725422 ·Status: RECRUITING
-
Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
NCT01240850 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut
NCT07157189 ·Status: NOT_YET_RECRUITING
-
Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis
NCT01681940 ·Status: COMPLETED ·Phase: PHASE2
-
Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease
NCT03770663 ·Status: UNKNOWN ·Phase: PHASE3
-
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
NCT00103792 ·Status: COMPLETED ·Phase: PHASE3
-
Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides
NCT00751517 ·Status: UNKNOWN ·Phase: PHASE2
-
Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)
NCT04978740 ·Status: COMPLETED ·Phase: NA
-
Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.
NCT06276036 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Serum Sclerostin Levels in Cholesteatoma Patients
NCT03954288 ·Status: UNKNOWN
-
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
NCT00001764 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
NCT04944524 ·Status: UNKNOWN ·Phase: PHASE4